Vertex Pharmaceuticals' GAAP net income for 9 months of 2023 was $2.651 billion, up 5.9% from $2.503 billion in the prior year. Revenue increased 10.9% to $7.352 billion compared to $6.628 billion a year earlier.
Vertex Pharmaceuticals' GAAP net income for 9 months of 2023 was $2.651 billion, up 5.9% from $2.503 billion in the prior year. Revenue increased 10.9% to $7.352 billion compared to $6.628 billion a year earlier. 
investors.vrtx.com
English (US) 